Risk Factors for Late HIV Presentation in Patients Treated at a Single Belgian Reference Centre from 2018 to 2022

Author:

Scaia Damien1,Fombellida Karine2,Maes Nathalie3ORCID,El Moussaoui Majdouline2ORCID,Darcis Gilles2ORCID

Affiliation:

1. Public Health Science Department, University of Liège, 4000 Liège, Belgium

2. Infectious Diseases Department, Liège University Hospital, 4000 Liège, Belgium

3. Biostatistics and Research Method Center, Liège University Hospital, 4000 Liège, Belgium

Abstract

A late HIV diagnosis is associated with increased mortality and morbidity, increased healthcare costs and increased onward viral transmission. In this regard, we retrospectively analysed the characteristics of patients who presented for care at our centre from January 2018 to December 2022 to assess the proportion of patients and factors associated with late HIV presentation. We collected data from the Liège University Hospital database, and we used binary logistic regression models to analyse the impact of individuals’ characteristics on late presentation. Among 167 participants, 38.3% were late presenters (LPs) (presenting for care with a CD4+ T-cell count < 350 cells/mm3 or after an AIDS-defining event), and 21.6% were late presenters with advanced disease (LPs-AD) (presenting for care with a CD4+ T-cell count < 200 cells/mm3 or after an AIDS-defining event). The risk of being an LPs-AD was increased in older individuals (OR on log-transformed age: 7.5) and individuals of sub-Saharan African origin compared to individuals of Belgian or other origin (ORs of 0.30 and 0.25, respectively). The results of this study suggest that broadening the focus beyond the previously common risk groups is essential to prevent late diagnosis.

Funder

Léon Fredericq Foundation

Publisher

MDPI AG

Reference36 articles.

1. Determinants of Long-Term Survival in Late HIV Presenters: The Prospective PISCIS Cohort Study;Bruguera;eClinicalMedicine,2022

2. World Health Organization, Regional Office for Europe, and European Centre for Disease Prevention and Control (2021). HIV/AIDS Surveillance in Europe 2021, European Centre for Disease Prevention and Control. 2020, Data.

3. Deblonde, J., De Rouck, M., Montourcy, M., Serrien, B., and Van Beckhoven, D. (2021). Épidémiologie du SIDA et de L’infection à VIH en Belgique. Situation au 31 Décembre 2020, Sciensano. Rapport 2021.

4. Mortality according to CD4 Count at Start of Combination Antiretroviral Therapy among HIV-Infected Patients followed for up to 15 Years after Start of Treatment: Collaborative Cohort Study;May;Clin. Infect. Dis.,2016

5. The Late Presentation Working Groups in EuroSIDA and COHERE (2020). Estimating the Burden of HIV Late Presentation and Its Attributable Morbidity and Mortality across Europe 2010–2016. BMC Infect. Dis., 20.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3